Seeking Alpha

Shares of Questcor Pharmaceuticals (QCOR) plunge 19.5% premarket after the company discloses a...

Shares of Questcor Pharmaceuticals (QCOR) plunge 19.5% premarket after the company discloses a government probe into its marketing practices.
Comments (3)
  • WACG
    , contributor
    Comments (377) | Send Message
     
    A government probe? A PROBE!? HA HA HA!!! I can virtually guarantee that nothing will become of it except more static and noise. Why? "Marketing Practices" is code for promoting off label usage. The indication approval for Acthar is so broad that a rep would need to be promoting it for ED and/or crabgrass. Eventually the dim-bulbs will blink their eyes and wonder how they were duped AGAIN. True, the Swoop and Scoop on stop losses will be ugly but c'est la vie. (Hint: Never margin pharma stocks.)
    24 Sep 2012, 09:20 AM Reply Like
  • TruffelPig
    , contributor
    Comments (4077) | Send Message
     
    Agree 100% with you.
    24 Sep 2012, 11:08 AM Reply Like
  • Melvin7501
    , contributor
    Comments (72) | Send Message
     
    What is your assessment on QCOR rebounding to it $58 dollar mark timewise?? It does continue to sport a $64 dollar PT by one analyst...
    29 Sep 2012, 06:54 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs